V Duvert
Schering-Plough
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by V Duvert.
Current Topics in Microbiology and Immunology | 1992
Sem Saeland; I. Moreau; V Duvert; D. Pandrau; J. Bancherau
Purified B cell precursors (BCP) (CD10+ CD19+ surface-membrane (s)Ig-cells) isolated from human fetal bone marrow (BM) were cultured with various cytokines, in the presence or absence of a fibroblastic stromal cell layer derived from adult human BM. We demonstrated that IL-7, IL-3, and stem-cell factor (SCF) participate in inducing low magnitude BCP proliferation in the absence of stroma. Addition of either IL-4, IFN (alpha and gamma), or TGF beta, resulted in significant inhibition of proliferation. Strikingly, BCP proliferated at remarkably higher levels when cultured on BM stromal cells, and this effect was further enhanced by exogenously supplied IL-7. Proliferating cells were mostly CD20+, and included both c mu- and c mu+ cells. Furthermore, BCP proliferated in response to anti CD40 antibody presented by Fc gamma RII-transfected murine fibroblastic Ltk- cells (CD40 system) (Banchereau et al. 1991), demonstrating a functional role for CD40 in B cell ontogeny. However, this effect was shown to require a second signal, which could be specifically provided by IL-3 among a panel of cytokines examined. Finally, although suggestive of BCP maturation, the culture systems examined did not permit the transition to mature B cells (sIgM+ sIgD+).
Leukemia Research | 1997
Nathalie Renard; Nobuyuki Harada; Evelyne Callet-Bauchu; Atsushi Miyajima; V Duvert; Jacques Banchereau; Sem Saeland
The present study describes two novel cell lines, DUNATIS and SILVANUS, established from B lineage acute lymphoblastic leukemia patients. Respectively, DUNATIS and SILVANUS display an early pre-B cell and a pre-B cell phenotype. Spontaneous DNA replication of both cell lines was strongly inhibited by IL-4. This effect was directly mediated by IL-4 and exerted through the CD124 IL-4 receptor chain. Notably, IL-4 was associated with rapid cell death and reduction of cellularity in DUNATIS, whereas these parameters were considerably less pronounced and only observed after longer-term exposure of the SILVANUS cells to IL-4. In addition to these differences, although both cell lines expressed FES oncoprotein, a 100 kDa protein associated with FES was strikingly found to be tyrosine-phosphorylated in response to IL-4 exclusively in DUNATIS cells. These data demonstrate that IL-4 displays heterogenous effects on leukemic B cell precursors responsive to inhibition of DNA synthesis via IL-4 mediated engagement of the CD124 receptor chain. The present findings may be of use for appreciation of the effects of IL-4 in B lineage ALL, and the novel cell lines could represent a model for further identification of target molecules in IL-4 signalling.
Blood | 1990
Christophe Caux; Sem Saeland; C Favre; V Duvert; Patrice Mannoni; Jacques Banchereau
Journal of Experimental Medicine | 1997
Leopoldo Flores-Romo; Pia Björck; V Duvert; Cees van Kooten; Sem Saeland; Jacques Banchereau
Journal of Experimental Medicine | 1993
Sem Saeland; V Duvert; I Moreau; Jacques Banchereau
Blood | 1991
Christophe Caux; C Favre; Sem Saeland; V Duvert; Isabelle Durand; Patrice Mannoni; Jacques Banchereau
Blood | 1993
Isabelle Moreau; V Duvert; Christophe Caux; Marie-Christine Galmiche; Pierre Charbord; Jacques Banchereau; Sem Saeland
Blood | 1991
Sem Saeland; V Duvert; Dominique Pandrau; Christophe Caux; Isabelle Durand; Nicholas Wrighton; Janusz Wideman; Frank S. Lee; Jacques Banchereau
Blood | 1994
N Renard; V Duvert; Jacques Banchereau; Sem Saeland
Journal of Experimental Medicine | 1993
Christophe Caux; Isabelle Durand; I Moreau; V Duvert; Sem Saeland; Jacques Banchereau